ZNF32 and neoplasm: However, ZNF32-enhanced tumor growth was decreased by the application of the TGF-βR inhibitor LY2157299 (Figures 5a and b), suggesting that ZNF32 could protect AC cells and maintain their rapid growth in vivo through the TGF-βR pathway in response to anti-tumor drug administration.